NDC 65162-841 – Lubiprostone
Lubiprostone 8 ug/1 · Capsule · Oral
Product NDC65162-841
Product details
- Brand name
- Lubiprostone
- Generic name
- Lubiprostone
- Labeler
- Amneal Pharmaceuticals LLC
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA209450
- Marketed since
- December 3, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Chloride Channel Activator
Active ingredients
- Lubiprostone 8 ug/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 65162-841-06 | 60 CAPSULE in 1 BOTTLE (65162-841-06) | Dec 3, 2021 |
| 65162-841-18 | 180 CAPSULE in 1 BOTTLE (65162-841-18) | Dec 3, 2021 |
Other Lubiprostone products
- 65162-842 Lubiprostone 24 ug/1 · Capsule · Amneal Pharmaceuticals LLC
- 76420-777 Lubiprostone 8 ug/1 · Capsule · Asclemed USA, Inc.
- 76420-778 Lubiprostone 24 ug/1 · Capsule · Asclemed USA, Inc.
- 31722-403 Lubiprostone .008 mg/1 · Capsule · Camber Pharmaceuticals, Inc.
- 31722-404 Lubiprostone .024 mg/1 · Capsule · Camber Pharmaceuticals, Inc.
- 72603-289 Lubiprostone .024 mg/1 · Capsule · Northstar Rx LLC
- 72603-288 Lubiprostone .008 mg/1 · Capsule · Northstar Rx LLC
- 70771-1763 Lubiprostone 8 ug/1 · Capsule · Zydus Lifesciences Limited
- 70771-1764 Lubiprostone 24 ug/1 · Capsule · Zydus Lifesciences Limited
- 70710-1641 Lubiprostone 8 ug/1 · Capsule · Zydus Pharmaceuticals USA Inc.
- 70710-1642 Lubiprostone 24 ug/1 · Capsule · Zydus Pharmaceuticals USA Inc.
- 80425-0354 Lubiprostone 8 ug/1 · Capsule, Gelatin Coated · Advanced Rx of Tennessee, LLC